共 50 条
- [42] Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
- [44] Personalizing antiplatelet therapy-moving to clinics European Journal of Clinical Pharmacology, 2013, 69 : 1191 - 1191